Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

389 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Systemic CD4 Immunity and PD-L1/PD-1 Blockade Immunotherapy.
Escors D, Bocanegra A, Chocarro L, Blanco E, Piñeiro-Hermida S, Garnica M, Fernandez-Rubio L, Vera R, Arasanz H, Kochan G. Escors D, et al. Among authors: vera r. Int J Mol Sci. 2022 Oct 31;23(21):13241. doi: 10.3390/ijms232113241. Int J Mol Sci. 2022. PMID: 36362027 Free PMC article. Review.
Cutting-Edge CAR Engineering: Beyond T Cells.
Chocarro L, Blanco E, Fernández-Rubio L, Arasanz H, Bocanegra A, Echaide M, Garnica M, Ramos P, Piñeiro-Hermida S, Vera R, Kochan G, Escors D. Chocarro L, et al. Among authors: vera r. Biomedicines. 2022 Nov 24;10(12):3035. doi: 10.3390/biomedicines10123035. Biomedicines. 2022. PMID: 36551788 Free PMC article. Review.
Oleuropein-driven reprogramming of the myeloid cell compartment to sensitise tumours to PD-1/PD-L1 blockade strategies.
Blanco E, Silva-Pilipich N, Bocanegra A, Chocarro L, Procopio A, Ausín K, Fernandez-Irigoyen J, Fernández L, Razquin N, Igea A, Garnica M, Echaide M, Arasanz H, Vera R, Escors D, Smerdou C, Kochan G. Blanco E, et al. Among authors: vera r. Br J Cancer. 2024 Mar;130(5):869-879. doi: 10.1038/s41416-023-02561-y. Epub 2024 Jan 9. Br J Cancer. 2024. PMID: 38195888 Free PMC article.
Cytokines and Lymphoid Populations as Potential Biomarkers in Locally and Borderline Pancreatic Adenocarcinoma.
González-Borja I, Viúdez A, Alors-Pérez E, Goñi S, Amat I, Ghanem I, Pazo-Cid R, Feliu J, Alonso L, López C, Arrazubi V, Gallego J, Pérez-Sanz J, Hernández-García I, Vera R, Castaño JP, Fernández-Irigoyen J. González-Borja I, et al. Among authors: vera r. Cancers (Basel). 2022 Dec 5;14(23):5993. doi: 10.3390/cancers14235993. Cancers (Basel). 2022. PMID: 36497475 Free PMC article.
Erratum to: Tailored Prevention of Functional Decline through a Multicomponent Exercise Program in Hospitalized Oncogeriatric Patients: Study Protocol for a Randomized Clinical Trial.
Martínez-Velilla N, Arrazubi V, Zambom-Ferraresi F, Morilla-Ruiz I, Sáez de Asteasu ML, Ramírez-Vélez R, De la Casa-Marín A, Ollo-Martínez I, Gorospe-García I, Gurruchaga-Sotés I, Galbete A, Cedeño-Veloz BA, Martín-Nevado L, Izquierdo M, Vera R. Martínez-Velilla N, et al. Among authors: vera r. J Nutr Health Aging. 2023 Dec;27(12):1287. doi: 10.1007/s12603-023-2033-7. J Nutr Health Aging. 2023. PMID: 38242605 Free article. No abstract available.
Quality of life in Spanish postmenopausal breast cancer patients with localized disease who finish endocrine treatment: a prospective study.
Arraras JI, Illarramendi JJ, Manterola A, de la Cruz S, Zarandona U, Ibañez B, Salgado E, Visus I, Barrado M, Teiejira L, Martinez MI, Martinez E, Vera R. Arraras JI, et al. Among authors: vera r. Menopause. 2023 Jun 1;30(6):613-620. doi: 10.1097/GME.0000000000002178. Epub 2023 Apr 4. Menopause. 2023. PMID: 37022296
Quality of life of early-stage breast-cancer patients diagnosed with COVID-19 in the first three waves of the epidemic treated in the Spanish region of Navarre.
Arraras JI, Illarramendi JJ, Manterola A, Cruz S, Zarandona U, Ibañez B, Salgado E, Visus I, Barrado M, Teijeira L, Martinez E, Vera R. Arraras JI, et al. Among authors: vera r. Psychooncology. 2023 May;32(5):730-740. doi: 10.1002/pon.6118. Epub 2023 Mar 17. Psychooncology. 2023. PMID: 36882856
Total neoadjuvant therapy with or without aflibercept in rectal cancer: 3-year results of GEMCAD-1402.
Pesántez D, Ten Hoorn S, Machado I, García-Albéniz X, Rodríguez-Salas N, Heredia-Soto V, Viñal D, Pericay C, García-Carbonero R, Losa F, Alonso V, Vera R, Feliu Batlle J, Gallego J, Salud A, Nogué M, Layos L, Montagut C, Capdevila J, Vermeulen L, Maurel J, Fernandez-Martos C. Pesántez D, et al. Among authors: vera r. J Natl Cancer Inst. 2023 Dec 6;115(12):1497-1505. doi: 10.1093/jnci/djad120. J Natl Cancer Inst. 2023. PMID: 37405857 Clinical Trial.
389 results